- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Corcept Therapeutics Incorporated (CORT)
38.11
+2.40(+6.72%)
Closed
After Hours
37.45-0.66(-1.73%)
Fair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
35.87
38.18
52 wk Range
20.84
39.75
CORT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Assess today's live Corcept Therapeutics Incorporated (CORT) share price, performance and insights using our live NASDAQ: CORT stock exchange data.
Analyse the historical data and Corcept Therapeutics Incorporated share price performance charts on this page. Our technical summary section provides analysis on Corcept share price buy/sell indicators using real-time data (or discuss the Corcept (CORT) stock price today with other investors in the Corcept NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CORT share price (ISIN: US2183521028) to enhance your trading decisions with our free investment tools and resources.
What Is the Corcept Therapeutics Incorporated Share Price Today?
The Corcept share price today is 38.11.
What Is the Stock Symbol for Corcept Therapeutics Incorporated
The stock symbol (or 'ticker') for Corcept Therapeutics Incorporated is "CORT."
What Stock Exchange Does Corcept Therapeutics Incorporated Trade On?
Corcept Therapeutics Incorporated is listed and trades on the NASDAQ stock exchange.
Is Corcept Therapeutics Incorporated a Good Stock to Buy?
Determining whether Corcept Therapeutics Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Corcept Therapeutics Incorporated share price performance charts on this page. Our technical summary section provides analysis on Corcept share price buy/sell indicators using real-time data (or discuss the Corcept (CORT) stock price today with other investors in the Corcept NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CORT share price (ISIN: US2183521028) to enhance your trading decisions with our free investment tools and resources.
What Is the Corcept Therapeutics Incorporated Share Price Today?
The Corcept share price today is 38.11.
What Is the Stock Symbol for Corcept Therapeutics Incorporated
The stock symbol (or 'ticker') for Corcept Therapeutics Incorporated is "CORT."
What Stock Exchange Does Corcept Therapeutics Incorporated Trade On?
Corcept Therapeutics Incorporated is listed and trades on the NASDAQ stock exchange.
Is Corcept Therapeutics Incorporated a Good Stock to Buy?
Determining whether Corcept Therapeutics Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
35.8738.18
52 wk Range
20.8439.75
UnlockCORT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
59.60
Upside
+56.39%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Corcept Company Profile
Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing’s syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of cushing’s syndrome; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; treatment for prostate cancer which is in phase II clinical trial; and nab-paclitaxel in combination with relacorilant, which is in phase III clinical trial to treat platinum-resistant ovarian tumors. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; miricorilant, which is in phase IIb trial for the treatment of nonalcoholic steatohepatitis; and treatment for antipsychotic induced weight gain that is in phase I trial. The company was incorporated in 1998 and is headquartered in Menlo Park, California.
Compare CORT to Peers and Sector
Metrics to compare | CORT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCORTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.9x | −0.9x | −0.6x | |
PEG Ratio | 0.81 | 0.00 | 0.00 | |
Price/Book | 6.7x | 3.3x | 2.6x | |
Price / LTM Sales | 7.0x | 2.4x | 3.1x | |
Upside (Analyst Target) | 70.6% | 54.0% | 55.7% | |
Fair Value Upside | Unlock | 6.5% | 6.9% | Unlock |
People Also Watch
FAQ
What Is the Corcept (CORT) Stock Price Today?
The Corcept stock price today is 38.11
What Stock Exchange Does Corcept Trade On?
Corcept is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Corcept?
The stock symbol for Corcept is "CORT."
What Is the Corcept Market Cap?
As of today, Corcept market cap is 3.98B.
What is Corcept Earnings Per Share?
The Corcept EPS is 1.22.
What Is the Next Corcept Earnings Date?
Corcept will release its next earnings report on 30 Oct 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.